1,000
Participants
Start Date
April 30, 2021
Primary Completion Date
March 31, 2022
Study Completion Date
May 15, 2023
Blood
a blood sample will be taken during hospitalisation for diagnostic confirmation or during the quarterly multidisciplinary consultations scheduled as part of the standard follow-up set up for these patients in the ALS centres of the FILSLAN network. If the genetic status is not yet known, this sample will be taken (1 tube of 7mL EDTA) and then sent within 24-48 hours at room temperature to one of the 3 participating molecular biology laboratories according to the criteria defined in the manual of samples being taken in the 3 laboratories.
CHU Marseille, Marseille
CHU Caen, Caen
CHU Dijon, Dijon
CHU de Brest, Brest
CHU Toulouse, Toulouse
CHU Bordeaux, Bordeaux
CHU Montpellier, Montpellier
CHU de Rennes, Rennes
University hospital, Tours
CHU St Etienne, Saint-Priest-en-Jarez
CHU Angers, Angers
CHU Nancy, Nancy
CHU Lille, Lille
CHU Clermont Ferrand, Clermont-Ferrand
CHU Strasbourg, Strasbourg
CHU Lyon, Bron
Paris - Groupe hospitalier de la Pitié Salpetrière, Paris
CHU Limoges, Limoges
CHU La Réunion, Saint-Pierre
CHU Nice, Nice
Collaborators (1)
Biogen
INDUSTRY
University Hospital, Tours
OTHER